Tocagen’s mission is to become a leading biopharmaceutical company for the treatment of cancer using cancer-selective gene therapy products based on their retroviral gene therapy platforms to increase lifespan, initially for patients with advanced local and metastatic cancer. Their broadly applicable product candidates are designed to activate a patient’s immune system against their cancer
…More from within.